MEI Pharma Balance Sheet Health
Financial Health criteria checks 6/6
MEI Pharma has a total shareholder equity of $59.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $78.5M and $19.1M respectively. MEI Pharma's EBIT is $15.0M making its interest coverage ratio -3.8. It has cash and short-term investments of $59.5M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -3.8x |
| Cash | US$59.48m |
| Equity | US$59.49m |
| Total liabilities | US$19.05m |
| Total assets | US$78.54m |
Recent financial health updates
We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely
May 18
We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate
Nov 04Recent updates
New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)
Feb 17Increases to CEO Compensation Might Be Put On Hold For Now at MEI Pharma, Inc. (NASDAQ:MEIP)
Dec 30Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP)
Nov 19We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely
May 18Need To Know: The Consensus Just Cut Its MEI Pharma, Inc. (NASDAQ:MEIP) Estimates For 2022
Mar 26Newsflash: MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Have Been Trimming Their Revenue Forecasts
Feb 12MEI Pharma: Another PI3K Delta Progressing To The FDA
Feb 01Need To Know: Analysts Just Made A Substantial Cut To Their MEI Pharma, Inc. (NASDAQ:MEIP) Estimates
Dec 02We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate
Nov 04MEI Pharma EPS misses by $0.12, misses on revenue
May 06MEI Pharma promotes Richard Ghalie to chief medical officer
Apr 30MEI Pharma shares rise 4% as Wells Fargo says voruciclib undervalued
Apr 26The Independent Non-Executive Director of MEI Pharma, Inc. (NASDAQ:MEIP), Frederick Driscoll, Just Sold 40% Of Their Holding
Feb 25New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)
Feb 11
MEI Pharma EPS beats by $0.01, beats on revenue
Feb 04Financial Position Analysis
Short Term Liabilities: MEIP's short term assets ($66.2M) exceed its short term liabilities ($8.0M).
Long Term Liabilities: MEIP's short term assets ($66.2M) exceed its long term liabilities ($11.0M).
Debt to Equity History and Analysis
Debt Level: MEIP is debt free.
Reducing Debt: MEIP has not had any debt for past 5 years.
Debt Coverage: MEIP has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: MEIP has no debt, therefore coverage of interest payments is not a concern.